The Duke Funding Alert newsletter, published every Monday, provides information on all new and updated grants and fellowships added to the database during the prior week. This listserv is restricted to members of the Duke community.
Myocarditis is a rare disease, and many medical professionals lack the resources needed to care for affected patients. That’s why the Myocarditis Foundation is proud to sponsor myocarditis research grants dedicated to diagnosis, treatment and an eventual cure. If you’re interested in conducting research related to myocarditis, our grants could help you take the next step on the journey to eradicating this disease.
One of the most critical aspects of myocarditis research is encouraging promising physician-scientists to devote their talents to this important work. To do so, the Myocarditis Foundation Research Grant supports the training and career development of those who are dedicated to the study of myocarditis. Research Grants are intended to offer seed funding to support the early stages of long-term research, from the investigation of an initial hypothesis to the collection of preliminary data.
Grant recipients will receive a $40,000 stipend payable over the course of one year. This amount does not include additional funding for benefits, travel and/or other costs associated with research. At the end of the grant period, recipients should be well-prepared to seek long-term funding from the National Institute of Health (NIH) or other major granting institution.
Deadline: Dec. 1, 2019
Candidates may apply up to 10 years following receipt of an MD, PhD, or an equivalent degree and plan to perform the funded work in the United States or Canada, in order to apply for the Fellowship. All applicants must select a preceptor with a proven track record of research in myocarditis. In addition to providing a letter of recommendation, the preceptor is expected to assist in preparing the application. For applicants wishing advice in the selection of a preceptor, a list of potential preceptors is available from the MF.